8-K
Current Report
IRulya Therapeutics Inc. Filed Acc 0001193125-23-019103
Results of operations · Exit or restructuring costs · Other events
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d442243d8k.htm…